Literature DB >> 17356888

Multifocal electroretinogram for assessing sun damage following the solar eclipse of 29 March 2006: multifocal electroretinography in solar maculopathy.

Hatice Arda1, Ayse Oner, Sait Mutlu, Ziya Köse, Koray Gumus, Sarper Karakucuk, Ertugrul Mirza.   

Abstract

AIM: To evaluate the clinical findings and multifocal electroretinography results of cases with solar maculopathy due to eclipse watching. PATIENTS AND
METHOD: Eight eyes of six patients (ages ranged 12-42) who presented to our clinic after the solar eclipse of 29 March 2006 were evaluated in the study. All patients underwent a full ophthalmologic examination and multifocal electroretinography (mfERG).
RESULTS: Visual acuities at the initial examination were between 20/32 and 20/20; and at final examination between 20/25 and 20/20 respectively. Fundoscopic examination disclosed macular pigmentary changes in almost all patients. Fundus Fluorescein Angiography revealed a window defect in six eyes. The initial findings of the mfERG at the first visit showed a decrease in the P1 and N1 amplitudes of the central responses. The following mfERG recordings showed a recovery in central P1 and N1 amplitudes.
CONCLUSION: Decrease in P1 and N1 amplitudes of central macular region can be detected by mfERG in patients with solar maculopathy. Follow-up mfERG test results may recover with the increase of visual acuity.

Entities:  

Mesh:

Year:  2007        PMID: 17356888     DOI: 10.1007/s10633-007-9049-x

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   1.854


  15 in total

1.  The multifocal ERG: unmasked by selective cross-correlation.

Authors:  David Keating; Stuart Parks; Donald Smith; Aled Evans
Journal:  Vision Res       Date:  2002-12       Impact factor: 1.886

2.  Evaluation of successful macular hole surgery by optical coherence tomography and multifocal electroretinography.

Authors:  Michael N Apostolopoulos; Chryssanthi N Koutsandrea; Michael N Moschos; Dimitrios A Alonistiotis; Alexis E Papaspyrou; John A Mallias; Theodora E Kyriaki; Panagiotis G Theodossiadis; George P Theodossiadis
Journal:  Am J Ophthalmol       Date:  2002-11       Impact factor: 5.258

3.  Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities.

Authors:  M F Marmor; F Tan
Journal:  Arch Ophthalmol       Date:  1999-02

4.  The field topography of ERG components in man--I. The photopic luminance response.

Authors:  E E Sutter; D Tran
Journal:  Vision Res       Date:  1992-03       Impact factor: 1.886

5.  Solar retinopathy. A study from Nepal and from Germany.

Authors:  N Rai; L Thuladar; F Brandt; G B Arden; T A Berninger
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

6.  [Multifocal electroretinogram for assessing sun damage following the solar eclipse of 11 August 1999].

Authors:  G Mack; J L Uzel; J Sahel; J Flament
Journal:  J Fr Ophtalmol       Date:  2002-04       Impact factor: 0.818

7.  [Microperimetry and reading saccades in retinopathia solaris. Follow-up with the scanning laser ophthalmoscope].

Authors:  O Ehrt; I Tavcar; G Eckl-Titz
Journal:  Ophthalmologe       Date:  1999-05       Impact factor: 1.059

8.  Eclipse retinopathy.

Authors:  M Michaelides; R Rajendram; J Marshall; S Keightley
Journal:  Eye (Lond)       Date:  2001-04       Impact factor: 3.775

9.  Exposure to a solar eclipse causes neuronal death in the retina.

Authors:  S Thanos; P Heiduschka; I Romann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-10       Impact factor: 3.117

10.  Multifocal electroretinography and optical coherence tomography in two patients with solar retinopathy.

Authors:  Patrik Schatz; Urban Eriksson; Vesna Ponjavic; Sten Andréasson
Journal:  Acta Ophthalmol Scand       Date:  2004-08
View more
  1 in total

1.  Correlation of macular structure and function in a boy with primary foveomacular retinitis and sequence of changes over 5 years.

Authors:  Anurag Badhani; Tapas Ranjan Padhi; Gopal Krishna Panda; Sujoy Mukherjee; Taraprasad Das; Subhadra Jalali
Journal:  Doc Ophthalmol       Date:  2017-04-27       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.